Kiyoshi Hirahara
Overview
Explore the profile of Kiyoshi Hirahara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
3850
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishimura K, Aoki T, Kobayashi M, Takami M, Ozaki K, Ogawa K, et al.
Cancer Sci
. 2025 Feb;
PMID: 39916425
While antibody-dependent cellular cytotoxicity (ADCC) by anti-disialoganglioside GD2 monoclonal antibody (mAb) has succeeded in increasing the survival rate of high-risk patients with neuroblastoma, approximately 40%-50% of patients die from the...
2.
Sugihara J, Iwamura C, Tateishi T, Hosoya T, Shimada S, Hirahara K, et al.
Clinics (Sao Paulo)
. 2025 Jan;
80:100584.
PMID: 39879907
Background: Post-acute COVID-19 Syndrome (PACS) occurs in some COVID-19 patients long after acute infection and significantly affects patients' health. However, the mechanism by which PACS develops is unknown. Myosin light...
3.
Kaneko T, Iwamura C, Kiuchi M, Kurosugi A, Onoue M, Matsumura T, et al.
J Allergy Clin Immunol Glob
. 2024 Jul;
3(3):100287.
PMID: 39040657
Background: Massive eosinophil infiltration into the esophagus is associated with subepithelial fibrosis and esophageal stricture in patients with eosinophilic esophagitis (EoE). However, the pathogenesis of esophageal fibrosis remains unclear. Objective:...
4.
Aoki A, Iwamura C, Kiuchi M, Tsuji K, Sasaki A, Hishiya T, et al.
J Clin Immunol
. 2024 Apr;
44(4):104.
PMID: 38647550
Purpose: Auto-antibodies (auto-abs) to type I interferons (IFNs) have been identified in patients with life-threatening coronavirus disease 2019 (COVID-19), suggesting that the presence of auto-abs may be a risk factor...
5.
Hatano R, Lee E, Sato H, Kiuchi M, Hirahara K, Nakagawa Y, et al.
Mol Metab
. 2024 Apr;
84:101934.
PMID: 38604598
Objectives: During fasting, liver pivotally regulates blood glucose levels through glycogenolysis and gluconeogenesis. Kidney also produces glucose through gluconeogenesis. Gluconeogenic genes are transactivated by fasting, but their expression patterns are...
6.
7.
Tanaka S, Yamamoto T, Iwata A, Kiuchi M, Kokubo K, Iinuma T, et al.
Arthritis Res Ther
. 2024 Feb;
26(1):55.
PMID: 38378635
Objectives: IgG4-related disease (IgG4-RD) is a systemic autoimmune disease with an unknown etiology, affecting single/multiple organ(s). Pathological findings include the infiltration of IgG4-producing plasma cells, obliterative phlebitis, and storiform fibrosis....
8.
Kumagai J, Kiuchi M, Kokubo K, Yagyu H, Nemoto M, Tsuji K, et al.
Proc Natl Acad Sci U S A
. 2023 Nov;
120(49):e2302903120.
PMID: 38015852
Uncontrolled type 2 immunity by type 2 helper T (Th2) cells causes intractable allergic diseases; however, whether the interaction of CD4 T cells shapes the pathophysiology of allergic diseases remains...
9.
Suga K, Kiuchi M, Kageyama T, Kokubo K, Tanaka S, Iwata A, et al.
Allergol Int
. 2023 Jun;
72(4):610-613.
PMID: 37349231
No abstract available.
10.
Koyama-Nasu R, Kimura M, Kiuchi M, Aoki A, Wang Y, Mita Y, et al.
Cancer Immunol Res
. 2023 May;
11(8):1085-1099.
PMID: 37216576
Tumor-specific CD8+ T cells play a pivotal role in antitumor immunity and are a key target of immunotherapeutic approaches. Intratumoral CD8+ T cells are heterogeneous; Tcf1+ stemlike CD8+ T cells...